BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jimenez J, Sakthivel M, Nischal KK, Fedorchak MV. Drug delivery systems and novel formulations to improve treatment of rare corneal disease. Drug Discov Today 2019;24:1564-74. [PMID: 30872110 DOI: 10.1016/j.drudis.2019.03.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Mobaraki M, Soltani M, Zare Harofte S, L Zoudani E, Daliri R, Aghamirsalim M, Raahemifar K. Biodegradable Nanoparticle for Cornea Drug Delivery: Focus Review. Pharmaceutics 2020;12:E1232. [PMID: 33353013 DOI: 10.3390/pharmaceutics12121232] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
2 Rupenthal ID, Daugherty AL. Ocular drugs and drug delivery systems — Current trends and future perspectives. Drug Discovery Today 2019;24:1425-6. [DOI: 10.1016/j.drudis.2019.07.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Jimenez J, Washington MA, Resnick JL, Nischal KK, Fedorchak MV. A sustained release cysteamine microsphere/thermoresponsive gel eyedrop for corneal cystinosis improves drug stability. Drug Deliv Transl Res 2021;11:2224-38. [PMID: 33543397 DOI: 10.1007/s13346-020-00890-6] [Reference Citation Analysis]
4 Campos PM, Petrilli R, Lopez RFV. The prominence of the dosage form design to treat ocular diseases. Int J Pharm 2020;586:119577. [PMID: 32622806 DOI: 10.1016/j.ijpharm.2020.119577] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]